FDA approves HPV prevention tag for Gardasil

By DrBicuspid Staff

July 6, 2020 -- The U.S. Food and Drug Administration (FDA) has approved labeling for Gardasil 9, an HPV vaccine, stating that it prevents oropharyngeal and other head and neck cancers caused by the virus.

The FDA is requesting that Gardasil's maker, Merck Sharp & Dohme, continue to study this particular clinical benefit; if postmarketing studies do not confirm the use of Gardasil for preventing these cancers, its clearance may be withdrawn or modified, the FDA said.


Copyright © 2020 DrBicuspid.com
 

To read this and get access to all of the exclusive content on DrBicuspid.com create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a DrBicuspid.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: